A swine flu vaccine has been approved in China and inoculations could begin in the next few weeks.
The vaccine, PANFLU.1, was developed by Sinovac Biotech Ltd and is suitable for people aged three to 60.
The South China Morning Post reports Health Minister Chen Zhu as saying that some 200,000 people taking part in the anniversary celebrations will be the first to receive the vaccine.
The Chinese State Food and Drug Administration (SFDA) last week approved two factories to produce the vaccine -- Sinovac, based in Beijing, and Hualan Biological Engineering, based in Henan -- according to the Post.
Hartl said that in Europe, several drug firms are set to submit clinical trial data in the next few weeks, with GlaxoSmithKline likely to be among the first.